Astellas Pharma Inc. announced plans to create an integrated biotechnology campus in South San Francisco as its West Coast innovation and research center. The...
Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") announced that it has discontinued development of fezagepras.
The decision to discontinue the development of fezagepras is...
ZyVersa Therapeutics, Inc., a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates that address unmet medical needs in the...
Univar Solutions Inc., a leading global solutions provider to users of specialty ingredients and chemicals, announced that NexusBioAg, a division of Univar Solutions, and...
Carl Zeiss Meditec and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, announced that the companies have entered...
